SCHEMBL24309790

SCHEMBL24309790

Cn1cc(SNc2nc(Oc3ccccc3)cc(C3=CCOC(C)(C)C3)n2)cn1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566600 0.82 HTR1A (0.37) GPR39
SCHEMBL24309632 0.82 HTR1A (0.37) GPR39
SCHEMBL24309688 0.81 MAPK1 (0.46) GPR39
SCHEMBL24309625 0.80 TDP1 (0.38) GPR39
SCHEMBL24310349 0.80 GPR39 (0.35) GPR39
SCHEMBL24310347 0.78 GPR39 (0.39) GPR39
SCHEMBL24309634 0.77 CACNA1B (0.33) GPR39
SCHEMBL24309787 0.76 MAPT (0.36) GPR39
SCHEMBL24309663 0.76 GPR39 (0.37) GPR39
SCHEMBL24309788 0.73 GCK (0.36) GPR39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback